Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    FAM59B Antibody, mFluor Violet 500 SE, Novus Biologicals™
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP241118MFV500
Description
FAM59B Polyclonal antibody specifically detects FAM59B in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry (Paraffin)Specifications
| FAM59B | |
| Polyclonal | |
| Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin | |
| FAM59B, Family With Sequence Similarity 59, Member B, GAREML, GRB2 Associated, Regulator Of MAPK1-Like, GRB2-Associated And Regulator Of MAPK Protein-Like, GRB2-Associated And Regulator Of MAPK1-Like, KIAA2038, Protein FAM59B | |
| Antibody was raised against a 19 amino acid synthetic peptide from near the carboxy terminus of human FAM59B. The immunogen is located within amino acids 600 - 650 of FAM59B. Amino Acid Squence: PPLFKPSHPQKRFAPFGA | |
| 0.1 mL | |
| Signal Transduction | |
| 150946 | |
| Store at 4C in the dark. | |
| IgG | 
| Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunohistochemistry (Paraffin) | |
| mFluor Violet 500 SE | |
| 50mM Sodium Borate | |
| Rabbit | |
| Peptide affinity purified | |
| RUO | |
| Primary | |
| Human, Mouse, Rat | |
| Purified | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction